Blood Res.
2013 Jun;48(2):72-73. 10.5045/br.2013.48.2.72.
Plerixafor use for peripheral blood stem cell mobilization in Korea
- Affiliations
-
- 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 2Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, Korea.
- 3Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea.
- 4Hematologic Malignancy Branch, National Cancer Center, Ilsan, Korea.
- 5Department of Internal Medicine, St. Mary Hospital, The Catholic University of Korea, Seoul, Korea.
- 6Department of Internal Medicine, Seoul National University Hospiltal, Seoul, Korea.
- 7Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
- KMID: 2172902
- DOI: http://doi.org/10.5045/br.2013.48.2.72
Abstract
- No abstract available.
MeSH Terms
Cited by 1 articles
-
Hematopoietic stem cell mobilization: current status and future perspective
Jin Seok Kim
Blood Res. 2017;52(2):79-81. doi: 10.5045/br.2017.52.2.79.
Reference
-
1. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995; 86:3961–3969. PMID: 7579367.
Article2. Gordan LN, Sugrue MW, Lynch JW, et al. Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation. Leuk Lymphoma. 2003; 44:815–820. PMID: 12802919.
Article3. DiPersio JF, Micallef IN, Stiff PJ, et al. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol. 2009; 27:4767–4773. PMID: 19720922.
Article
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Hematopoietic stem cell mobilization: current status and future perspective
- Current Status of G-CSF Based Stem Cell Therapy for Patients with Myocardial Infarction
- Determining the Optimal Time for Peripheral Blood Stem Cell Harvest by Detecting Immature Cells using Hematology Analyzer, SE-9000TM IMI Channel
- The Correlation between G-CSF Dosage and the Number of Collected CD34+ Cells in Pediatric Patients Undergoing Peripheral Blood Stem Cell Mobilization
- Effect of Fixed Dose of G-CSF on Mobilization and Engraftment of Peripheral Blood Stem Cells in High Dose Chemotherapy
